Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival

Annals of Epidemiology

Volumn 15, Issue 10, 2005, Pages 773-780

  Hill, Teresa D ^a,b   Khamis, Harry J ^b   Tyczynski, Jerzy E ^a,b   Berkel, Hans J ^a,b  

^a Cancer Prevention Institute Dayton   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Breast Neoplasms Female; Breast Neoplasms Male; Epidemiology; Hormone Receptor; SEER Program; Survival

Indexed keywords

ESTROGEN; PROGESTERONE RECEPTOR;

ADULT; ANALYTIC METHOD; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; RISK FACTORS; SEER PROGRAM; SEX FACTORS; SURVIVAL;

EID: 27644557151     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2005.01.001     Document Type: Article

References (25)

1. A. Jemal, R.C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, and E. Ward Cancer statistics, 2004 CA Cancer J Clin 54 2004 8 29
2. M.G. Joshi, A.K. Lee, M. Loda, M.G. Camus, C. Pedersen, and G.J. Heatley Male breast carcinoma: An evaluation of prognostic factors contributing to a poorer outcome Cancer 77 1996 490 498
3. P. Gattuso, V.B. Reddy, L. Green, M. Castelli, D. Haley, and C. Herman Prognostic significance of DNA ploidy in male breast carcinoma. A retrospective analysis of 32 cases Cancer 70 1992 777 780
4. B. Cutuli, M. Lacroze, J.M. Dilhuydy, M. Velten, B. De Lafontan, and C. Marchal Male breast cancer: Results of the treatments and prognostic factors in 397 cases Eur J Cancer 31A 1995 1960 1964
5. P.I. Borgen, R.T. Senie, W.M. McKinnon, and P.P. Rosen Carcinoma of the male breast: Analysis of prognosis compared with matched female patients Ann Surg Oncol 4 1997 385 388
6. K. Herman, W. Lobaziewicz, P. Skotnicki, J. Fortuna, T. Kusy, and T. Lesniak Male breast cancer. Does the prognosis differ compared to female? Neoplasma 47 2000 191 195
7. B. Sandler, C. Carman, and R.R. Perry Cancer of the male breast Am Surg 60 1994 816 820
8. R. Steinitz, L. Katz, and M. Ben-Hur Male breast cancer in Israel: Selected epidemiological aspects Isr J Med Sci 17 1981 816 821
9. M. Ewertz, L. Holmberg, S. Karjalainen, S. Tretli, and H.O. Adami Incidence of male breast cancer in Scandinavia, 1943-1982 Int J Cancer 43S 1989 27 31
10. E. Crocetti, and E. Buiatti Male breast cancer: Incidence, mortality and survival rates from an Italian population-based series Eur J Cancer 30A 1994 1732 1733
11. J.G. Jonasson, B.A. Agnarsson, S. Thorlacius, J.E. Eyfjord, and H. Tulinius Male breast cancer in Iceland Int J Cancer 65 1996 446 449
12. A.J. Sasco, A.B. Lowenfels, and P. Pasker-de Jong Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors Int J Cancer 53 1993 538 549
13. P.C. Willsher, I.H. Leach, I.O. Ellis, J.B. Bourke, R.W. Blamey, and J.F. Robertson A comparison outcome of male breast cancer with female breast cancer Am J Surg 173 1997 185 188
14. W.F. Anderson, M.D. Althuis, L.A. Brinton, and S.S. Devesa Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83 2004 77 86
15. C. Atalay, M. Kanlioz, and M. Altinok Prognostic factors affecting survival in male breast cancer J Exp Clin Cancer Res 22 2003 29 33
16. M.B. El-Tamer, I.K. Komenaka, A. Troxel, H. Li, K.A. Joseph, and B.A. Ditkoff Men with breast cancer have better disease-specific survival than women Arch Surg 139 2004 1079 1082
17. Surveillance Epidemiology and End Results (SEER) Program (www.cancer.seer.gov ) Public-Use Data. Public-Use Data (1973-1999). Released April 2002, based on the November 2001 submission. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch.
18. Surveillance Epidemiology and End Results (SEER) Program (www.cancer.seer.gov ) Public-Use Data. Public-Use Data (1973-2001). Released April 2004, based on the November 2003 submission. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch.
19. H.J. Kim, M.P. Fay, E.J. Feuer, and D.N. Midthune Permutation tests for joinpoint regression with applications to cancer rates Stat Med 19 2000 335 351
20. National Cancer Institute. Joinpoint Regression Program. 2002, National Cancer Institute.
21. Surveillance Research Program. National Cancer Institute SEER*Stat Software Available at: seer.cancer.gov/seerstat. Accessed July 17, 2004.
22. SPSS Inc. SPSS, Version 10.0 1999 SPSS Inc. Chicago, IL
23. SAS Institute, Inc. SAS 9.0 1999 SAS Institute, Inc. Cary, NC
24. N. Breen, D.K. Wagener, M.L. Brown, W.W. Davis, and R. Ballard-Barbash Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys J Natl Cancer Inst 93 2001 1704 1713
25. F. Levi, L. Randimbison, and C. La Vecchia Breast cancer survival in relation to sex and age Oncology 49 1992 413 417